PoliticalRepoPoliticalRepo

Bill · HR

H.R. 830 (119th)

SAFE Act

Original

referredUnited States· United States Congress· EN

Introduced

31 January 2025

Last action

31 January 2025 · Introduced

Status

Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsors

Rep. Pappas, Chris [D-NH-1], Rep. Salazar, Maria Elvira [R-FL-27], Rep. Newhouse, Dan [R-WA-4], Rep. Crow, Jason [D-CO-6], Rep. Houlahan, Chrissy [D-PA-6], Shomari Figures, Rep. Craig, Angie [D-MN-2], Rep. McClellan, Jennifer L. [D-VA-4], Rep. Budzinski, Nikki [D-IL-13], Johnny Olszewski, Rep. Peters, Scott H. [D-CA-50], Rep. Connolly, Gerald E. [D-VA-11], Gilbert Cisneros, Rep. Davids, Sharice [D-KS-3], Rep. Ruiz, Raul [D-CA-25], Rep. Bera, Ami [D-CA-6], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Magaziner, Seth [D-RI-2]

Subjects

Discovery layer

Source updated

11 July 2026

Official sourceDownload fileView documentsShare

Summary

Save Americans from the Fentanyl Emergency Act or the SAFE Act This bill permanently places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Fentanyl-related substances are currently regulated under schedule I through a temporary order issued by the Drug Enforcement Administration. The temporary order expires on March 31, 2025. It limits mandatory minimum penalties for certain offenses involving fentanyl-related substances, establishes a process to deschedule or remove certain fentanyl-related substances that have a low potential for abuse, and allows federal courts to vacate or reduce sentences for convictions involving a fentanyl-related substance that is descheduled or moved to a schedule other than schedule I or II. The bill establishes a new, alternative registration process for schedule I research. It also makes other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration. Finally, the bill requires the Government Accountability Office to analyze the implementation and impact of permanently placing fentanyl-related substances into schedule I of the Controlled Substances Act.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

  1. 31 January 2025

    Introduced

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    Source: IntroReferral

  2. 31 January 2025

    Introduced

    Introduced in House

    Source: IntroReferral

  3. 31 January 2025

    Introduced

    Introduced in House

    Source: IntroReferral

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

2 official files

Sponsors

Related records

No cross-record relationships stored yet.

Sources

PoliticalRepo is an index and interpretation layer, not the authoritative legal source.